Recombinant Human NY-ESO-1(HLA-A*02:01)(His-Avi Tag)

更多活动更多优惠,尽在翌圣商城》

批量采购, 请点击询价

产品说明书

FAQ

COA

已发表文献

NY-ESO-1 or New York esophageal squamous cell carcinoma 1 is a well-known cancer-testis antigen (CTAs) with re-expression in numerous cancer types. Its ability to elicit spontaneous humoral and cellular immune responses, together with its restricted expression pattern, have rendered it a good candidate target for cancer immunotherapy.

 

性能参数

Synonyms

MHC; MY-ESO-1; CT6.1; LAGE-2; CTAG1; CTAG1B; ESO1CTAG; LAGE2A; NY-ESO-1

Uniprot No.

A0A140T913(HLA-A*02:01)&P61769(B2M)&SLLMWITQV

Source

Recombinant Human NY-ESO-1 (HLA-A*02:01) Protein is expressed from HEK293 Cells with His tag and Avi tag at the C-terminal. It contains Gly25-Thr305(HLA-A*02:01),

Ile21-Met119(B2M) and SLLMWITQV peptide.

Molecular Weight

The protein has a predicted MW of 50.5 kDa. Due to glycosylation, the protein migrates to 55-60 kDa based on Tris-Bis PAGE result.

Purity

> 95% as determined by SDS-PAGE and HPLC.

Endotoxin

<1 EU per 1μg of the protein by the LAL method.

Formulation

Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.

Reconstitution

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

储存条件

The product should be stored at -25~-15℃ for 1 year from date of receipt.

2-7 days, 2 ~8 °C under sterile conditions after reconstitution.

3 months, -25~-15℃ under sterile conditions after reconstitution.

Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.

 

注意事项

1.Please operate with lab coats and disposable gloves,for your safety.

2.This product is for research use only.

 

产品数据

 

Ver. CN20230410

 

400-6111-883